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Abstract: 
Objective: To assess whether non-surgical periodontal treatment is associated with 
changes in serological markers of systemic inflammation. 
Materials and Methods: Thirty-five systemically healthy subjects with severe genera-
lized periodontitis meeting the inclusion criteria participated in a four-month single blind 
interventional trial of which thirty-two completed the study. Periodontal parameters and 
inflammatory markers [C-reactive protein (CRP) and plasma fibrinogen] and also the 
white blood cell count (WBC) were evaluated prior to and four months after delivery of 
intensive non-surgical periodontal therapy with simultaneous lavage of chlorhexidine 
0.1% from the tip of the ultrasonic instrument into the pockets. 
Results: Significant differences in serum CRP levels were observed four months after 
treatment compared to the baseline (1.85, SD=1.93 vs 2.46, SD=2.32, respectively, 
P<0.0001). Periodontal treatment also resulted in a significant difference in WBC and neu-
trophil counts compared to the baseline (P<0.0001). The reduction in fibrinogen levels 
was not significant at the end of the research period. Significant improvement in the pock-
et probing depth and clinical attachment level for pockets with initially 4-6 mm and then 
more than 7 mm depth was observed. Changes in plaque and bleeding scores were also 
statistically significant (82.75 vs. 35.84 and 19.03 vs. 1.81, respectively). 
Conclusion: Periodontal treatment is effective in reducing CRP levels and white blood 
cell count, while fibrinogen levels are not influenced by periodontal therapy. Periodontal 
treatment may therefore decrease the systemic inflammatory burden in patients with ad-
vanced periodontitis. 
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INTRODUCTION 
Emerging evidence from epidemiologic stu-
dies indicates that periodontal infection is as-
sociated with a moderate systemic inflamma-
tory response [1-3]. In more severe forms of 
this disease the ulcerated epithelial lining of 
the periodontal pocket may constitute a sub-
stantial surface area through, which lipopoly-
saccharide and other bacteria-derived antigenic 
structures challenge the immune system, trig-
gering the synthesis of several pro-
inflammatory cytokines among which inter-
leukin-6 (IL-6) named as messenger cytokine 
can travel from local inflamed tissue to the liv-
er where it initiates a change in the program of 
protein synthesis from the housekeeping pro-Radafshar et al.  Effect of Periodontal Treatment on Serum Inflammatory Markers 
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tein, albumin, to proteins characteristic of the 
acute phase response, including (but not li-
mited to) C-reactive protein (CRP), fibrinogen 
and haptoglobin.  
Made of five 23-KDa subunits, CRP, a mem-
ber of pentraxin family of proteins, is a globu-
lin which signals the inflammatory state in the 
body, and is now considered as a major cardi-
ovascular risk factor [4,5]. Like other acute 
phase proteins, liver is the primary source of 
CRP synthesis; however, recent data indicate 
that it can be derived from the cells of human 
atherosclerotic intima [6]. The role of CRP in 
the pathogenesis of atherosclerosis via differ-
ent mechanisms, such as augmenting the ex-
pression of local adhesion molecules, and LDL 
uptake by macrophages as well as its interac-
tion with complement at the vascular level has 
documented this reactant protein not simply as 
a marker of inflammation, but also as a predic-
tor of future cardiovascular events[7,8]. 
Based on a large series of prospective epide-
miological studies, CRP, when measured with 
new high-sensitivity assays (hs-CRP), strongly 
and independently predicts risk of myocardial 
infarction, stroke, peripheral arterial disease 
and sudden cardiac death even among appar-
ently healthy individuals [9,10]. In a previous 
study, we found that among acute myocardial 
infarction patients matched for traditional 
CVD risk factors, case with having periodontal 
disease, had significantly higher levels of CRP 
than those without periodontal disease. The 
patients were also matched for the infarct size 
[11]. 
The primary data on the association between 
periodontal disease and elevated serum CRP 
levels was reported by Ebersole et al [1], 
which suggested that certain treatments are 
capable of lowering serum CRP levels. In their 
pilot study, this inflammatory marker was re-
duced in the serum of patients after non-
surgical periodontal treatment along with non-
steroidal anti-inflammatory drug (flurbiprofen) 
intake. Since then numerous studies have been 
conducted investigating the impact of peri-
odontal infection and the total inflammatory 
burden on the host and whether the interven-
tional strategies aiming at eradication of bac-
terial niches in the periodontal pockets reverse 
the resultant systemic inflammatory state [12-
14]. However, based on a recent meta-analysis 
conducted in Medline (1960 to 2005), results 
from randomized controlled trials and single 
cohort studies do not show any significant dif-
ference in serum CRP levels before and after 
periodontal treatment [15]. Mentioning these 
controversial results, the aim of this prospec-
tive intervention trial was to assess whether 
intensive non-surgical periodontal treatment 
              
Table 1. Values of inflammatory markers and periodontal parameters at baseline and 4-months after periodontal
therapy. 
Parameters  Baseline   4
th Month    P Value  Mean SD    Mean  SD   
CRP (mg/l)  2.46 2.31    1.85  1.93    <0.0001 
Fibrinogen(mg/dl)  330.87 58.43   329.68  68.95    0.929 
NS 
WBC  7512.5   1769.4    6487.5  1261.27    <0.0001 
Neutrophil  4553.06 1658.39   3571.09 764.30   <0.0001 
PI  82.75 12.91   35.84  14.73    <0.0001 
BOP  19.03 2.13   1.81 1.76    <0.0001 
PPD (% 4-6 mm)   39.44 14.32   19.64  13.72    <0.0001 
PPD (% ≥7 mm)   10.47  9.33   2.07  3.81   <0.0001 
CAL (% 4-6 mm)   48.58 12.98   22.57 9.87    <0.0001 
CAL (% ≥7 mm)   13.11  10.94   2.93  4.42   <0.0001 
SD=Standard Deviation, PI=Plaque Index, BOP=Bleeding On Probing, PPD=Pocket Probing Depth, CAL=Clinical Attachment Level, NS= Not 
statistically Significant 
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was associated with changes in serological 
markers of systemic inflammation, i.e., CRP, 
fibrinogen and white blood cell count in oth-
erwise healthy individuals. 
 
MATERIALS AND METHODS 
A prospective, longitudinal, single blind, in-
terventional trial with a four-month follow up 
was conducted among thirty-five systemically 
healthy subjects (18 men, 17 women) in the 
age range of 19-56 years. The participants 
were recruited from non-smoking subjects of 
severe (probing pocket depth and attachment 
loss more than 5 mm, and radiographic evi-
dence of alveolar bone loss), generalized 
(more than 30% of sites affected), periodonti-
tis with at least 20 vital teeth  referred to the 
Department of Periodontology, Guilan Univer-
sity of Medical Sciences (GUMS), School of 
Dentistry. All the subjects had BMI (body 
mass index) of 20 to 27 kg/m². 
Exclusion criteria were considered as: (i) any 
periodontal treatment in the preceding six 
months (ii) known systemic diseases or any 
chronic inflammatory/infectious conditions 
such as arthritis, bronchitis, mucocutaneous 
conditions and sinusitis (iii) pregnancy or lac-
tation (iv) any antimicrobial treatment in the 
previous six months or treatment with any me-
dication affecting the serum level of inflamma-
tory makers such as anti-inflammatories, hor-
mone replacement and steroids, statins, immu-
nosuppressants and anti-coagulants. All pa-
tients gave written informed consent. This 
study was reviewed and approved by the 
GUMS ethics committee. 
Periodontal assessment including the pocket 
probing depth (PPD), clinical attachment level 
(CAL) – recorded at six sites per tooth; name-
ly, mesiobuccal, buccal, distobuccal, distolin-
gual, lingual and mesiolingual and CAL meas-
ured from the cemento enamel junction (CEJ) 
– bleeding on probing (Lenox & Kopczyk) for 
six anterior teeth of both jaws was carried out 
by a single examiner blinded to the study pro-
tocol at baseline and four months following 
periodontal treatment using a manual Williams 
periodontal probe (Hu-Friedy, IKK UNITY, 
USA) with a probe tip of 0.4 mm in diameter 
and a rounded working end. Plaque index 
(O’Leary) was recorded for all scorable, fully 
erupted teeth. The American Heart Association 
(AHA) and the Center for Disease Control 
(CDC) in a joint consensus report, released a 
guideline for cardiovascular risk assessment, 
which has identified three different risk cate-
gories merely based on serum CRP levels. 
Based on CRP levels; lower than 1 mg/l, 1-3 
mg/l and higher than 3 mg/l, patients are cate-
gorized as low risk, medium risk and high risk 
for future cardiovascular disease and/or events, 
respectively [16]. We further categorized the 
patients according to this guideline, before and 
after intervention. 
Each subject provided a 5 ml venous blood 
sample at baseline and underwent a non-
surgical periodontal treatment starting with 
intensive oral hygiene instruction followed by 
deep ultrasonic instrumentation using a mag-
neto-restrictive device equipped with constant 
flow of 0.1% chlorhexidine digluconate from 
its tip into the pockets during instrumentation. 
        
Table 2. Mean decrease in PPD and attachment level gain for 4-6 mm and more than 7 mm pocket depths following 
treatment. 
Parameters Min  Max  Mean  SD 
PPD Decrease (4-6 mm)  1.1  4.2  2.37  0.79 
PPD Decrease (≥7 mm)  1.1 5.3 2.82  0.9 
CAL Gain (4-6 mm)  1.2  3.9  2.38  0.74 
CAL Gain (≥7 mm)  1 4.7  2.85  0.87 
SD=Standard Deviation, PPD=Pocket Probing Depth, CAL=Clinical Attachment Level 
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Mechanical therapy was completed in two un-
limited time appointments with one-week in-
terval between the sessions. Subjects were in-
structed to brush their teeth and tongue with a 
soft toothbrush and Listerine toothpaste. An 
Oral-B anti-septic mouthwash (Oral-B Labora-
tories, Ireland) was also prescribed for the pa-
tients to use for two weeks. Plaque control and 
oral hygiene instructions were repeated appro-
priately during the four- month follow up, after 
which a full periodontal reassessment was car-
ried out and further blood samples were taken. 
Peripheral blood samples were taken and fro-
zen at - 20ºC until use. CRP determination was 
performed with a highly sensitive enzyme-
linked immunosorbent assay (ADBC, Diag-
nostics Biochem. Canada Inc., detection limit 
of 10 ng/l) and the plasma fibrinogen level was 
performed using the digital coagulation tech-
nique (Plasma Te clot, Manufactured by 
TECO GmbH, Germany). WBC and neutro-
phil counts were detected immediately, using a 
cell counter device (KX21N, Sysmex, Kobe, 
Japan) and cell differentiation was controlled 
with a peripheral blood smear. 
Using previous estimates of variance for the 
primary outcome such as changes in the level 
of inflammatory markers following periodon-
tal treatment [17], the sample size was based 
on formal calculation methods. Baseline and 
reassessment data were compared using paired 
t-test. Data were analyzed by SPSS version 16 
and a p value of 0.05 was assumed significant. 
 
RESULTS 
Totally, 32 participants completed the study. 
Three patients refused to give the second 
blood sample and were excluded from the 
study population. Together with positive 
changes in parameters of periodontal disease, 
non-surgical periodontal therapy resulted in a 
significant reduction in the circulating levels 
of CRP and WBC/neutrophil counts. No sig-
nificant changes occurred in the concentration 
of fibrinogen four months after the completion 
of periodontal treatment (Table 1). 
Table 1 also illustrates the findings of clinical 
periodontal parameters at baseline and at the 
reassessment visit, indicating significant im-
provements in plaque, bleeding scores and also 
in the percent of pockets with the initial PD of 
4-6 mm and more than 7 mm (P<0.0001). 
There were similar findings for CAL gain in 
the sites initially having an attachment loss of 
4-6 mm and more than 7 mm. Table 2 illu-
strates mean reduction values for PPD and 
mean CAL gain in pockets with an initial PD 
and CAL of more than 4 mm.  
According to AHA/CDC categorization, at 
baseline, 12 patients were in the low risk 
group, and 10 in each of the medium and high 
risk groups. Four months after intervention, 
there was a shift from medium and high to-
ward the lower risk groups. 
 
DISCUSSION 
This study aimed at examining the effect of 
extensive full mouth non-surgical periodontal 
treatment on the level of systemic inflammato-
ry indicators, which also play an important 
role as risk markers for cardiovascular disease. 
We showed that eradication or suppression of 
periodontal pathogens not only from the peri-
odontal pockets but also from all their intra-
oral habitats (mucous membranes, tongue and 
saliva) by applying full mouth disinfection in a 
relatively short time period [18], was asso-
ciated with a significant decrease in serum 
CRP levels and WBC/neutrophil counts in 
otherwise healthy individuals affected by se-
vere generalized periodontitis. 
Accumulating evidence has shown that treat-
ment of severe periodontitis is associated with 
subsequent changes in the level of serum in-
flammatory markers [12,14,19-22]. However, 
some other investigations have reported con-
troversial results [23,24]. Ide et al [24] re-
ported no statistically significant changes in 
the level of CRP, IL-6 and IL-1β following a 
single course of periodontal treatment. Al-Journal of Dentistry, Tehran University of Medical Sciences   Radafshar et al. 
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though they excluded current smokers, they 
did not assess the effect of obesity or hyper-
tension. Obesity is one of the typical subclini-
cal conditions associated with higher CRP val-
ues. In our study, all the subjects had a BMI 
between 20 and 27 kg/m²; therefore, they were 
not apparently obese. 
Offenbacher et al [25], in a secondary cardiac 
event prevention model, showed that periodon-
tal intervention significantly lowers the hs-
CRP levels in patients with baseline CRP val-
ues higher than 3 mg/l, after 6 months. How-
ever, as a strong confounder, obesity nullified 
the periodontal treatment effects on hs-CRP 
reduction in their study. 
Furthermore, we also excluded subjects with 
any other infectious or inflammatory condi-
tions or those taking any medications, which 
could affect the level of systemic variables un-
der investigation and subjects with hyperten-
sion.  
In a recent case-control study, Vidal et al [26] 
measured the serum level of CRP, IL-6 and 
fibrinogen after non-surgical periodontal ther-
apy in refractory arterial hypertensive patients 
affected by severe periodontitis. They reported 
significant decrease in plasma variables 3 
months after intervention in addition to the 
improvement of periodontal clinical results 
they had reached. 
On the other hand, according to Jastrzebski et 
al [27], in the presence of hypertension and 
other cardiovascular risk factors such as 
hypercholesterolemia, obesity, and diabetes 
mellitus, the impact of periodontal treatment 
on the total inflammatory burden (as was im-
plicated by serum CRP and fibrinogen levels) 
is small. 
Unlike Jastrzebski et al [27], Lalla et al [28], 
in a pilot study showed decreased secretion of 
serum CRP and soluble E selectin, by blood-
derived macrophages in diabetic patients four 
weeks after full mouth subgingival debride-
ment.  
The present study may be compared with that 
of Marcaccini et al [21] with respect to CRP, 
Ellis et al [29], and also Buhlin et al [30] with 
respect to both CRP and fibrinogen levels and 
WBC counts, following periodontal treatment. 
Similar to our findings, in the two studies 
mentioned above, no significant changes were 
induced by periodontal therapy on fibrinogen 
levels. 
Despite the consisting data indicating the pre-
dictive value of plasma fibrinogen levels in 
CVD/stroke risk assessment, and also the cu-
mulative effect of hs-CRP and fibrinogen in 
risk prediction, fibrinogen evaluation has 
found limited use in clinical practice because 
of suboptimal assay standardization; therefore 
consistency across reference laboratories re-
mains poor [22]. Since unlike CRP, highly 
sensitive assays for this marker have not been 
developed, it seems possible that with large-
scale studies, significant changes in fibrinogen 
levels also become evident. In this regard, it 
should also be mentioned that application of 
non-surgical periodontal treatment leaves be-
hind the chance of some residual diseased 
sites, especially in initially deep pockets, and 
this may have influenced our results. 
One of the other findings of the present study, 
although not measured as a primary outcome, 
was the change occurring in the CRP-
associated CVD risk among patients following 
successful non-surgical periodontal interven-
tion, which is in agreement with that of D'Ai-
uto F et al [14]. 
 
CONCLUSION 
Within the limitations of this study, successful 
non-surgical periodontal treatment results in 
significant decrease in serum CRP levels and 
WBC/neutrophil counts in otherwise healthy 
subjects. 
Due to the relatively small sample size, the 
results obtained here need to be interpreted 
with caution. In addition, it should be empha-
sized that in order to indefinitely demonstrate 
the potential benefits of periodontal therapy to Radafshar et al.  Effect of Periodontal Treatment on Serum Inflammatory Markers 
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reduce the level of serum inflammatory mark-
ers, and also of greater concern, whether 
treatment improves the overall cardiovascular 
risk, large multi-center randomized trials are 
suggested. 
Given the high prevalence of periodontal dis-
ease, and in the light of predictable periodontal 
treatment posing negligible risk and leading to 
a high standard of oral health, we suggest pe-
riodontal treatment to be considered as a part 
of the cardiovascular preventive program, both 
in the future study designs and clinical prac-
tice. 
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